Tammy Jean Beckett, FNP

Tammy Beckett practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Tammy Beckett's NPI, 1083945182, was assigned on January 29, 2010. Tammy Beckett holds Michigan license 4704216374.

Tammy Beckett's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Tammy Beckett's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Tammy Beckett is also affiliated with Trinity Health Grand Rapids Hospital. The medical group on file is Center for Physical Rehabilitation (CPR). Dmand AI also links Tammy Beckett to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tammy Beckett practices, 8 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Tammy Beckett's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Tammy Beckett is licensed in Michigan.

Dmand AI lists osteoporosis and tobacco use among the conditions Tammy Beckett treats.

CMS data shows 634 Medicare services from Tammy Beckett across 3 procedure codes in 2024, all of them office visits, for 535 Medicare patients. Medicare paid $42,090 for them. Every service was in an office.

CMS counts 535 Medicare patients who saw Tammy Beckett in 2024. The largest group is 65 to 74, with 281 patients. 75% of them have osteoporosis, and 66% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tammy Beckett's median patient age at 73, with 91% women.

In 2024, Tammy Beckett wrote 992 Medicare Part D claims for 303 patients. 65% of them were for generic drugs. CMS names the drug for 965 of them, across 6 drugs with 11 or more claims each, at $1,294,424 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Tammy Beckett for performance year 2024, reported as part of a group. Tammy Beckett accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 38 general payments to Tammy Beckett from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Amgen Inc. paid the most, $329.